Las Vegas, NV -- (SBWIRE) -- 01/24/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: New Residential Investment Corp(NYSE:NRZ), Rambus Inc.(NASDAQ:RMBS), Infinera Corp.(NASDAQ:INFN), Synta Pharmaceuticals Corp.(NASDAQ:SNTA)
New Residential Investment Corp(NYSE:NRZ) was a volume gainer of 2.11 million shares and the average volume of the stock remained 1.79 million shares. The stock opened the session at $6.35 and finished at the end of the day at $6.38 and the stock escalated 0.16%.The market capitalization of the stock remained 1.62 billion. New Residential Investment Corp., a real estate investment trust, focuses on investing in residential mortgage related assets. The company is involved in the direct and indirect investments in excess mortgage servicing rights; and in real estate securities and loans.
For How Long NRZ will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Rambus Inc.(NASDAQ:RMBS) exchanged 2.09 million shares and the average volume remained 1.42 million shares. The stock closed the session at $9.5 with the gain of 6.15%. Rambus Inc. invents, develops, offers, and licenses technology solutions. The company also develops products and services in security, light-emitting diodes lighting and displays, and immersive mobile media. The company was founded in 1990 and is headquartered in Sunnyvale, California.
Will RMBS Continue To Move Higher? Find Out Here
Infinera Corp.(NASDAQ:INFN) decreased -2.89% and its closing price was $7.40. The volume of the stock was 2.03 million shares and the average volume remained 1.77 million shares. The market capitalization of the stock remained 884.23 million. Infinera Corporation provides optical networking equipment, software, and services to communications service providers, Internet content providers, cable operators, and subsea network operators worldwide.
Will INFN Get Buyers Even After The Recent Rally? Find Out Here
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) exchanged 2.00 million shares in the previous trading session, and its average trading remained 1.93 million shares. SNTA advanced 3.61% and it closed the trading at $6.32. The market capitalization of the stock remained 538.48 million. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.
For How Long SNTA’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)